Edition:
United States

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

8.24USD
21 Feb 2017
Change (% chg)

-- (--)
Prev Close
$8.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
191,920
52-wk High
$10.00
52-wk Low
$3.67

CORT.OQ

Chart for CORT.OQ

About

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company's focus is on those disorders that are associated with a steroid hormone cortisol. Elevated levels and abnormal release... (more)

Overall

Beta: 1.74
Market Cap(Mil.): $914.90
Shares Outstanding(Mil.): 111.03
Dividend: --
Yield (%): --

Financials

  CORT.OQ Industry Sector
P/E (TTM): 209.78 28.39 29.32
EPS (TTM): 0.04 -- --
ROI: 14.80 13.54 13.03
ROE: 20.13 14.43 14.17

BRIEF-Corcept Therapeutics reports Q4 preliminary GAAP earnings per share $0.04

* Corcept Therapeutics announces preliminary fourth quarter and full-year 2016 financial results and corporate update; provides 2017 revenue guidance

Jan 30 2017

BRIEF-Corcept Therapeutics Q3 gaap earnings per share $0.02

* Says expects that its revenue for 2016 will be $79-82 million, an increase from its original guidance of $76-81 million

Nov 01 2016

More From Around the Web

Competitors

Earnings vs. Estimates